TY - JOUR
T1 - Meditation and cardiovascular risk reduction a scientific statement from the American Heart Association
AU - Council on Hypertension
AU - On behalf of the American Heart Association Council on Clinical Cardiology
AU - Council on Cardiovascular and Stroke Nursing
AU - Levine, Glenn N.
AU - Lange, Richard A.
AU - Bairey-Merz, C. Noel
AU - Davidson, Richard J.
AU - Jamerson, Kenneth
AU - Mehta, Puja K.
AU - Michos, Erin D.
AU - Norris, Keith
AU - Ray, Indranill Basu
AU - Saban, Karen L.
AU - Shah, Tina
AU - Stein, Richard
AU - Smith, Sidney C.
N1 - Publisher Copyright:
© 2017 The Authors.
PY - 2017/10/1
Y1 - 2017/10/1
N2 - Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary prevention of cardiovascular disease are of interest. Numerous studies have reported on the benefits ofmeditation. Meditation instruction and practice is widely accessible and inexpensive and may thus be a potential attractive cost-effective adjunct to more traditional medical therapies. Accordingly, this American Heart Association scientific statement systematically reviewed the data on the potential benefits of meditation on cardiovascular risk. Neurophysiological and neuroanatomical studies demonstrate that meditation can have long-standing effects on the brain, which provide some biological plausibility for beneficial consequences on the physiological basal state and on cardiovascular risk. Studies of the effects ofmeditation on cardiovascular risk have included those investigating physiological response to stress, smoking cessation, blood pressure reduction, insulin resistance and metabolic syndrome, endothelial function, inducible myocardial ischemia, and primary and secondary prevention of cardiovascular disease. Overall, studies of meditation suggest a possible benefit on cardiovascular risk, although the overall quality and, in some cases, quantity of study data are modest. Given the low costs and low risks of this intervention, meditation may be considered as an adjunct to guideline-directed cardiovascular risk reduction by those interested in this lifestyle modification, with the understanding that the benefits of such intervention remain to be better established. Further research onmeditation and cardiovascular risk iswarranted. Such studies, to the degree possible, should utilize randomized study design, be adequately powered to meet the primary study outcome, strive to achieve low drop-out rates, include long-termfollow-up, and be performed by those without inherent bias in outcome.
AB - Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary prevention of cardiovascular disease are of interest. Numerous studies have reported on the benefits ofmeditation. Meditation instruction and practice is widely accessible and inexpensive and may thus be a potential attractive cost-effective adjunct to more traditional medical therapies. Accordingly, this American Heart Association scientific statement systematically reviewed the data on the potential benefits of meditation on cardiovascular risk. Neurophysiological and neuroanatomical studies demonstrate that meditation can have long-standing effects on the brain, which provide some biological plausibility for beneficial consequences on the physiological basal state and on cardiovascular risk. Studies of the effects ofmeditation on cardiovascular risk have included those investigating physiological response to stress, smoking cessation, blood pressure reduction, insulin resistance and metabolic syndrome, endothelial function, inducible myocardial ischemia, and primary and secondary prevention of cardiovascular disease. Overall, studies of meditation suggest a possible benefit on cardiovascular risk, although the overall quality and, in some cases, quantity of study data are modest. Given the low costs and low risks of this intervention, meditation may be considered as an adjunct to guideline-directed cardiovascular risk reduction by those interested in this lifestyle modification, with the understanding that the benefits of such intervention remain to be better established. Further research onmeditation and cardiovascular risk iswarranted. Such studies, to the degree possible, should utilize randomized study design, be adequately powered to meet the primary study outcome, strive to achieve low drop-out rates, include long-termfollow-up, and be performed by those without inherent bias in outcome.
KW - AHA Scientific Statements
KW - Cardiovascular disease
KW - Cardiovascular risk
KW - Meditation
KW - Primary prevention
KW - Secondary prevention
UR - http://www.scopus.com/inward/record.url?scp=85032194935&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85032194935&partnerID=8YFLogxK
U2 - 10.1161/JAHA.117.002218
DO - 10.1161/JAHA.117.002218
M3 - Article
C2 - 28963100
AN - SCOPUS:85032194935
SN - 2047-9980
VL - 6
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 10
M1 - e002218
ER -